BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Mangia A, Cenderello G, Verucchi G, Ciancio A, Fontana A, Piazzolla V, Minerva N, Squillante MM, Copetti M. Is positivity for hepatitis C virus antibody predictive of lower risk of death in COVID-19 patients with cirrhosis? World J Clin Cases 2020; 8(22): 5831-5834 [PMID: 33344581 DOI: 10.12998/wjcc.v8.i22.5831]
URL: https://www.wjgnet.com/1007-9327/full/v8/i22/5831.htm
Number Citing Articles
David L. Fisher , Stephen Malnick. Liver and COVID-19 - A Review and Clinical ApproachCoronaviruses 2022; 3(1) doi: 10.2174/2666796702666211005142343
Paul Middleton, Catherine Hsu, Mark P Lythgoe. Clinical outcomes in COVID-19 and cirrhosis: a systematic review and meta-analysis of observational studiesBMJ Open Gastroenterology 2021; 8(1): e000739 doi: 10.1136/bmjgast-2021-000739
Host Response to SARS-CoV2 and Emerging Variants in Pre-Existing Liver and Gastrointestinal DiseasesFrontiers in Cellular and Infection Microbiology 2021; 11 doi: 10.3389/fcimb.2021.753249
Shimaa Afify, Basem Eysa, Fatma Abdel Hamid, Omnia M Abo-Elazm, Mohamed A Edris, Rabab Maher, Ahmed Abdelhalim, Muhammad Mostafa Abdel Ghaffar, Dalia A Omran, Hend Ibrahim Shousha. Survival and outcomes for co-infection of chronic hepatitis C with and without cirrhosis and COVID-19: A multicenter retrospective studyWorld Journal of Gastroenterology 2021; 27(42): 7362-7375 doi: 10.3748/wjg.v27.i42.7362
Fares E M Ali, Zuhair M Mohammedsaleh, Mahmoud M Ali, Osama M Ghogar. Impact of cytokine storm and systemic inflammation on liver impairment patients infected by SARS-CoV-2: Prospective therapeutic challengesWorld Journal of Gastroenterology 2021; 27(15): 1531-1552 doi: 10.3748/wjg.v27.i15.1531
Viola Guardigni, Elena Rosselli Del Turco, Lorenzo Badia, Silvia Galli, Kristian Scolz, Pierluigi Viale, Gabriella Verucchi. Pre-Existing HBV and HCV Infections Do Not Affect COVID-19-Related Outcomes: An Observational Retrospective StudyHepatitis Monthly 2021; 21(5) doi: 10.5812/hepatmon.116986
Nevio Cimolai. The Complexity of Co-Infections in the Era of COVID-19SN Comprehensive Clinical Medicine 2021; 3(7): 1502 doi: 10.1007/s42399-021-00913-4
Xinyu Hu, Longyan Sun, Zhaoyang Guo, Chao Wu, Xin Yu, Jie Li. Management of COVID-19 patients with chronic liver diseases and liver transplantsAnnals of Hepatology 2022; 27(1): 100653 doi: 10.1016/j.aohep.2021.100653
NitinA John, JyotiE John. Implication of COVID-19 in patients of HIV with hepatitis CJournal of Family Medicine and Primary Care 2022; 11(3): 828 doi: 10.4103/jfmpc.jfmpc_1090_21
Essamedin M. Negm. Does mass management of chronic hepatitis C protect the Egyptian population against fulminant coronavirus disease-2019? “Postulating a hypothesis”The Egyptian Journal of Bronchology 2022; 16(1) doi: 10.1186/s43168-022-00120-2
Manuela G. Neuman, Helmut K. Seitz, Rolf Teschke, Stephen Malnick, Kamisha L. Johnson-Davis, Lawrence B. Cohen, Anit German, Nicolas Hohmann, Bernhardo Moreira, George Moussa, Mihai Opris. Molecular, Viral and Clinical Features of Alcohol- and Non-Alcohol-Induced Liver InjuryCurrent Issues in Molecular Biology 2022; 44(3): 1294 doi: 10.3390/cimb44030087